FARN — Faron Pharmaceuticals Oy Share News
0.000.00%
Last trade - 00:00- £225.44m
- £227.66m
REG - Faron Pharma. Oy - Results of EGM
AnnouncementREG - Faron Pharma. Oy - Faron Appoints Interim Chief Medical Officer
AnnouncementREG - AIM - AIM Notice - 11/09/2023
AnnouncementREG - Faron Pharma. Oy - Change in the Board of Directors
AnnouncementRCS - Faron Pharma. Oy - Faron to Present at H.C. Wainwright Conference
AnnouncementREG - Faron Pharma. Oy - Notice of EGM
AnnouncementREG - Faron Pharma. Oy - Exercise of options
AnnouncementREG - Faron Pharma. Oy - Faron 2023 Half-Year Financial Results
AnnouncementREG - Faron Pharma. Oy - FDA Orphan Drug Designation for Bexmarilimab
AnnouncementREG - Faron Pharma. Oy - Notice of Half-Year Financial Results
AnnouncementRCS - Faron Pharma. Oy - Faron to Participate at Canaccord Conference
AnnouncementREG - Faron Pharma. Oy - Grant of Options
AnnouncementRCS - Faron Pharma. Oy - Faron to Hold BEXMAB Study Conference Call
AnnouncementREG - Faron Pharma. Oy - BEXMAB study update
AnnouncementREG - Faron Pharma. Oy - Holding(s) in Company
AnnouncementREG - AIM - AIM Notice - 30/06/2023
AnnouncementREG - Faron Pharma. Oy - Announcement of Placing
AnnouncementREG - Faron Pharma. Oy - Exercise of options
AnnouncementRCS - Faron Pharma. Oy - New biomarker data from BEXMAB study at EHA2023
Announcement